13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0001892688-24-000060
Total Value
$385.8M
Positions
15
Other Managers
1
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 2,253,183 | $89.3M | 23.15% |
| 2 | MERUS N V | N5749R100 | 1,509,007 | $68.0M | 17.61% |
| 3 | STOKE THERAPEUTICS INC | STOK | 3,696,820 | $49.9M | 12.94% |
| 4 | TSCAN THERAPEUTICS INC | TCRX | 5,224,600 | $41.5M | 10.75% |
| 5 | CABALETTA BIO INC | CABA | 2,082,973 | $35.5M | 9.21% |
| 6 | GH RESEARCH PLC | GHRS | 3,310,563 | $35.3M | 9.15% |
| 7 | C4 THERAPEUTICS INC | CCCC | 3,634,662 | $29.7M | 7.70% |
| 8 | SILENCE THERAPEUTICS PLC | SLNCF | 526,642 | $11.4M | 2.95% |
| 9 | AUTOLUS THERAPEUTICS PLC | AUTL | 1,390,160 | $8.9M | 2.30% |
| 10 | PASSAGE BIO INC | PASG | 4,845,871 | $6.5M | 1.70% |
| 11 | KINNATE BIOPHARMA INC | 49705R105 | 1,981,106 | $5.3M | 1.37% |
| 12 | NEKTAR THERAPEUTICS | NKTR | 2,068,842 | $1.9M | 0.50% |
| 13 | PIERIS PHARMACEUTICALS INC | 720795103 | 8,779,162 | $1.6M | 0.42% |
| 14 | BIONOMICS LIMITED | 09063M205 | 814,467 | $838,901 | 0.22% |
| 15 | CENTESSA PHARMACEUTICALS PLC | CNTA | 17,400 | $196,620 | 0.05% |